Biomarker assessment of PTEN protein expression and gene expression profiling (GEP) in a phase III study of copanlisib in combination with rituximab in patients with indolent non-Hodgkin lymphoma (iNHL) Meeting Abstract
| Authors: | Chaturvedi, S.; Schulz, A.; Soler, L. M.; Childs, B. H.; Matasar, M.; Zinzani, P. L. |
| Abstract Title: | Biomarker assessment of PTEN protein expression and gene expression profiling (GEP) in a phase III study of copanlisib in combination with rituximab in patients with indolent non-Hodgkin lymphoma (iNHL) |
| Meeting Title: | 113th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 82 |
| Issue: | 12 |
| Meeting Dates: | 2022 Apr 8-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2022-06-15 |
| Language: | English |
| ACCESSION: | WOS:000892509500095 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.AM2022-LB523 |
| Notes: | Meeting Abstract: LB523 -- Source: Wos |
